share_log

INNOVATE Corp Shares Are Trading Higher After the Company Announced on Friday That It Received FDA Approval for Its TGFR System for Accurate Kidney Function Testing.

INNOVATE Corp Shares Are Trading Higher After the Company Announced on Friday That It Received FDA Approval for Its TGFR System for Accurate Kidney Function Testing.

INNOVATE CORP的股票在公司宣佈獲得FDA批准其TGFR系統用於準確的腎功能檢測後上漲。
Benzinga ·  01/21 13:19

INNOVATE Corp Shares Are Trading Higher After the Company Announced on Friday That It Received FDA Approval for Its TGFR System for Accurate Kidney Function Testing.

INNOVATE CORP的股票在公司宣佈獲得FDA批准其TGFR系統用於準確的腎功能檢測後上漲。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論

    聲明

    本頁的譯文內容由軟件翻譯。富途將竭力但卻不能保證翻譯內容之準確和可靠,亦不會承擔因任何不準確或遺漏而引起的任何損失或損害。